MRKMerck & Co., Inc.vs its industry peers
A metric-by-metric comparison of Merck & Co., Inc. against its industry peers — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRKEsta | $325.6B#3 | 37.1x#4 | 7.1x#3 | 5.0x#3 | 1.3%#3 | 6.6%#3 | 34.2%#1 | 39.8%#1 | 21.5%#1 | — | 63.4%#1 | 2.5%#3 |
| PFE | $144.0B#4 | 19.3x#2 | 1.6x#1 | 2.3x#1 | -1.6%#5 | -3.2%#5 | 16.3%#5 | 8.6%#4 | 6.7%#5 | — | 11.0%#5 | 6.8%#1 |
| ABBV | $464.9B#2 | 129.6x#5 | — | 7.6x#5 | 8.6%#1 | -1.2%#4 | 24.6%#2 | — | 20.0%#2 | — | 41.0%#3 | 2.5%#4 |
| JNJ | $642.7B#1 | 30.9x#3 | 7.6x#4 | 6.8x#4 | 6.0%#2 | 90.6%#2 | 22.9%#3 | 31.5%#3 | 16.1%#3 | 6#2 | 61.6%#2 | 1.9%#5 |
| BMY | $129.9B#5 | 17.8x#1 | 6.5x#2 | 2.7x#2 | -0.2%#4 | 178.8%#1 | 21.8%#4 | 35.2%#2 | 14.4%#4 | 8#1 | 41.0%#4 | 3.9%#2 |
Peer set: Tickwind's hand-curated industry grouping. Values from SEC filings + delayed prices; ranks are sorted positions within this group only — descriptive, not a rating or advice. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-07-29.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice